Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian RandomizedControlled Triol, the WRITE study

Giuseppe Montalto

Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian RandomizedControlled Triol, the WRITE study

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Other › peer review

Lingua originale	English
Pagine	1001 A-1001 A
Numero di pagine	1
Stato di pubblicazione	Published - 2012

Altri file e collegamenti

OA Link

Cita questo

@conference{93c9bf5120c84bb8a0eaacdef8d9bd85,

title = "Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian RandomizedControlled Triol, the WRITE study",

keywords = "Chronic Hepatitis C, Genotypes, Peg-Interferon, Treatment, Chronic Hepatitis C, Genotypes, Peg-Interferon, Treatment",

author = "Giuseppe Montalto",

year = "2012",

language = "English",

pages = "1001 A--1001 A",

}

TY - CONF

T1 - Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of an ltalian RandomizedControlled Triol, the WRITE study

AU - Montalto, Giuseppe

PY - 2012

Y1 - 2012

KW - Chronic Hepatitis C

KW - Genotypes

KW - Peg-Interferon

KW - Treatment

KW - Chronic Hepatitis C

KW - Genotypes

KW - Peg-Interferon

KW - Treatment

UR - http://hdl.handle.net/10447/75024

M3 - Other

SP - 1001 A-1001 A

ER -